Adaptive immune-like γ/δ T lymphocytes share many common features with their α/β T cell counterparts

Journal of Immunology

Volumn 195, Issue 4, 2015, Pages 1449-1458

  Lombes, Amélie ^a,b   Durand, Aurélie ^a,b   Charvet, Céline ^a,b   Rivière, Matthieu ^a,b   Bonilla, Nelly ^a,b   Auffray, Cédric ^a,b   Lucas, Bruno ^a,b   Martin, Bruno ^a,b  

^a CNRS   (France)

^b INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; HERMES ANTIGEN; TRANSCRIPTION FACTOR FOXP3; INTERLEUKIN 17; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELTA T LYMPHOCYTE; GAMMA T LYMPHOCYTE; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH17 CELL; THYMUS; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION; GENETICS; HOMEOSTASIS; IMMUNOLOGY; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD27; ANTIGENS, CD44; ANTIGENS, LY; GENE EXPRESSION; HOMEOSTASIS; IMMUNOPHENOTYPING; INTERLEUKIN-17; LYMPHOPENIA; MICE; MICE, KNOCKOUT; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84938926325     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500375     Document Type: Article

References (60)

1. Carding, S. R., S. Kyes, E. J. Jenkinson, R. Kingston, K. Bottomly, J. J. Owen, and A. C. Hayday. 1990. Developmentally regulated fetal thymic and extrathymic T cell receptor gamma delta gene expression. Genes Dev. 4: 1304-1315.
2. McVay, L. D., and S. R. Carding. 1996. Extrathymic origin of human gamma delta T cells during fetal development. J. Immunol. 157: 2873-2882.
3. Carding, S. R., and P. J. Egan. 2002. Gammadelta T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2: 336-345.
4. Matis, L. A., A. M. Fry, R. Q. Cron, M. M. Cotterman, R. F. Dick, and J. A. Bluestone. 1989. Structure and specificity of a class II MHC alloreactive gamma delta T cell receptor heterodimer. Science 245: 746-749.
5. Crowley, M. P., Z. Reich, N. Mavaddat, J. D. Altman, and Y. Chien. 1997. The recognition of the nonclassical major histocompatibility complex (MHC) class I molecule, T10, by the gammadelta T cell, G8. J. Exp. Med. 185: 1223-1230.
6. Shin, S., R. El-Diwany, S. Schaffert, E. J. Adams, K. C. Garcia, P. Pereira, and Y. H. Chien. 2005. Antigen recognition determinants of gammadelta T cell receptors. Science 308: 252-255.
7. Adams, E. J., Y. H. Chien, and K. C. Garcia. 2005. Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22. Science 308: 227-231.
8. Scotet, E., L. O. Martinez, E. Grant, R. Barbaras, P. Jenö, M. Guiraud, B. Monsarrat, X. Saulquin, S. Maillet, J. P. Estève, et al. 2005. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 22: 71-80.
9. Shibata, K., H. Yamada, R. Nakamura, X. Sun, M. Itsumi, and Y. Yoshikai. 2008. Identification of CD25+ gamma delta T cells as fetal thymus-derived naturally occurring IL-17 producers. J. Immunol. 181: 5940-5947.
10. Pang, D. J., J. F. Neves, N. Sumaria, and D. J. Pennington. 2012. Understanding the complexity of gd T-cell subsets in mouse and human. Immunology 136: 283-290.
11. Ribot, J. C., A. deBarros, D. J. Pang, J. F. Neves, V. Peperzak, S. J. Roberts, M. Girardi, J. Borst, A. C. Hayday, D. J. Pennington, and B. Silva-Santos. 2009. CD27 is a thymic determinant of the balance between interferon-gamma-and interleukin 17-producing gammadelta T cell subsets. Nat. Immunol. 10: 427-436.
12. Wencker, M., G. Turchinovich, R. Di Marco Barros, L. Deban, A. Jandke, A. Cope, and A. C. Hayday. 2014. Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness. Nat. Immunol. 15: 80-87.
13. Ribot, J. C., M. Chaves-Ferreira, F. d'Orey, M. Wencker, N. Gonçalves-Sousa, J. Decalf, J. P. Simas, A. C. Hayday, and B. Silva-Santos. 2010. Cutting edge: adaptive versus innate receptor signals selectively control the pool sizes of murine IFN-g-or IL-17-producing gd T cells upon infection. J. Immunol. 185: 6421-6425.
14. Michel, M. L., D. J. Pang, S. F. Haque, A. J. Potocnik, D. J. Pennington, and A. C. Hayday. 2012. Interleukin 7 (IL-7) selectively promotes mouse and human IL-17-producing gd cells. Proc. Natl. Acad. Sci. USA 109: 17549-17554.
15. Jensen, K. D., X. Su, S. Shin, L. Li, S. Youssef, S. Yamasaki, L. Steinman, T. Saito, R. M. Locksley, M. M. Davis, et al. 2008. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 29: 90-100.
16. Turchinovich, G., and A. C. Hayday. 2011. Skint-1 identifies a common molecular mechanism for the development of interferon-g-secreting versus interleukin-17-secreting gd T cells. Immunity 35: 59-68.
17. Malissen, M., A. Gillet, L. Ardouin, G. Bouvier, J. Trucy, P. Ferrier, E. Vivier, and B. Malissen. 1995. Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J. 14: 4641-4653.
18. Delpoux, A., M. Poitrasson-Rivière, A. Le Campion, A. Pommier, P. Yakonowsky, S. Jacques, F. Letourneur, C. Randriamampita, B. Lucas, and C. Auffray. 2012. Foxp3-independent loss of regulatory CD4+ T-cell suppressive capacities induced by self-deprivation. Eur. J. Immunol. 42: 1237-1249.
19. Wang, Y., A. Kissenpfennig, M. Mingueneau, S. Richelme, P. Perrin, S. Chevrier, C. Genton, B. Lucas, J. P. DiSanto, H. Acha-Orbea, et al. 2008. Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCRMHC engagement and is insensitive to the action of Foxp3+ regulatory T cells. J. Immunol. 180: 1565-1575.
20. Le Campion, A., A. Pommier, A. Delpoux, L. Stouvenel, C. Auffray, B. Martin, and B. Lucas. 2012. IL-2 and IL-7 determine the homeostatic balance between the regulatory and conventional CD4+ T cell compartments during peripheral T cell reconstitution. J. Immunol. 189: 3339-3346.
21. Pommier, A., A. Audemard, A. Durand, R. Lengagne, A. Delpoux, B. Martin, L. Douguet, A. Le Campion, M. Kato, M. F. Avril, et al. 2013. Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells. Proc. Natl. Acad. Sci. USA 110: 13085-13090.
22. Narayan, K., K. E. Sylvia, N. Malhotra, C. C. Yin, G. Martens, T. Vallerskog, H. Kornfeld, N. Xiong, N. R. Cohen, M. B. Brenner, et al; Immunological Genome Project Consortium. 2012. Intrathymic programming of effector fates in three molecularly distinct gd T cell subtypes. Nat. Immunol. 13: 511-518.
23. Tough, D. F., and J. Sprent. 1994. Turnover of naive-and memory-phenotype T cells. J. Exp. Med. 179: 1127-1135.
24. Haas, J. D., S. Ravens, S. Düber, I. Sandrock, L. Oberdörfer, E. Kashani, V. Chennupati, L. Föhse, R. Naumann, S. Weiss, et al. 2012. Development of interleukin-17-producing gd T cells is restricted to a functional embryonic wave. Immunity 37: 48-59.
25. Pawelec, G., and A. Larbi. 2008. Immunity and ageing in man: Annual Review 2006/2007. Exp. Gerontol. 43: 34-38.
26. Weng, N. P. 2006. Aging of the immune system: how much can the adaptive immune system adapt? Immunity 24: 495-499.
27. Takada, K., and S. C. Jameson. 2009. Naive T cell homeostasis: from awareness of space to a sense of place. Nat. Rev. Immunol. 9: 823-832.
28. Martin, B., C. Bécourt, B. Bienvenu, and B. Lucas. 2006. Self-recognition is crucial for maintaining the peripheral CD4+ T-cell pool in a nonlymphopenic environment. Blood 108: 270-277.
29. Bluestone, J. A., C. R. Mackay, J. J. O'Shea, and B. Stockinger. 2009. The functional plasticity of T cell subsets. Nat. Rev. Immunol. 9: 811-816.
30. Cai, Y., F. Xue, C. Fleming, J. Yang, C. Ding, Y. Ma, M. Liu, H. G. Zhang, J. Zheng, N. Xiong, and J. Yan. 2014. Differential developmental requirement and peripheral regulation for dermal Vg4 and Vg6T17 cells in health and inflammation. Nat. Commun. 5: 3986.
31. Azzam, H. S., A. Grinberg, K. Lui, H. Shen, E. W. Shores, and P. E. Love. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188: 2301-2311.
32. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, andK. H.Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
33. Martin, B., K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen. 2009. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
34. Martin, B., C. Auffray, A. Delpoux, A. Pommier, A. Durand, C. Charvet, P. Yakonowsky, H. de Boysson, N. Bonilla, A. Audemard, et al. 2013. Highly self-reactive naive CD4 T cells are prone to differentiate into regulatory T cells. Nat. Commun. 4: 2209.
35. Murphy, A. G., K. M. O'Keeffe, S. J. Lalor, B. M. Maher, K. H. Mills, and R. M. McLoughlin. 2014. Staphylococcus aureus infection of mice expands a population of memory gd T cells that are protective against subsequent infection. J. Immunol. 192: 3697-3708.
36. Shen, Y., D. Zhou, L. Qiu, X. Lai, M. Simon, L. Shen, Z. Kou, Q. Wang, L. Jiang, J. Estep, et al. 2002. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 295: 2255-2258.
37. Pitard, V., D. Roumanes, X. Lafarge, L. Couzi, I. Garrigue, M. E. Lafon, P. Merville, J. F. Moreau, and J. Déchanet-Merville. 2008. Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. Blood 112: 1317-1324.
38. Le Campion, A., M. C. Gagnerault, C. Auffray, C. Bécourt, M. Poitrasson-Rivière, E. Lallemand, B. Bienvenu, B. Martin, F. Lepault, and B. Lucas. 2009. Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development. Blood 114: 1784-1793.
39. Kieper, W. C., A. Troy, J. T. Burghardt, C. Ramsey, J. Y. Lee, H. Q. Jiang, W. Dummer, H. Shen, J. J. Cebra, and C. D. Surh. 2005. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J. Immunol. 174: 3158-3163.
40. Baccala, R., D. Witherden, R. Gonzalez-Quintial, W. Dummer, C. D. Surh, W. L. Havran, and A. N. Theofilopoulos. 2005. Gamma delta T cell homeostasis is controlled by IL-7 and IL-15 together with subset-specific factors. J. Immunol. 174: 4606-4612.
41. Delpoux, A., P. Yakonowsky, A. Durand, C. Charvet, M. Valente, A. Pommier, N. Bonilla, B. Martin, C. Auffray, and B. Lucas. 2014. TCR signaling events are required for maintaining CD4 regulatory T cell numbers and suppressive capacities in the periphery. J. Immunol. 193: 5914-5923.
42. Chien, Y. H., C. Meyer, and M. Bonneville. 2014. gd T cells: first line of defense and beyond. Annu. Rev. Immunol. 32: 121-155.
43. Nanno, M., Y. Kanari, T. Naito, N. Inoue, T. Hisamatsu, H. Chinen, K. Sugimoto, Y. Shimomura, H. Yamagishi, T. Shiohara, et al. 2008. Exacerbating role of gammadelta T cells in chronic colitis of T-cell receptor alpha mutant mice. Gastroenterology 134: 481-490.
44. Mombaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75: 274-282.
45. Roark, C. L., J. D. French, M. A. Taylor, A. M. Bendele, W. K. Born, and R. L. O'Brien. 2007. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. J. Immunol. 179: 5576-5583.
46. Keystone, E. C., C. Rittershaus, N. Wood, K. M. Snow, J. Flatow, J. C. Purvis, L. Poplonski, and P. C. Kung. 1991. Elevation of a gamma delta T cell subset in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 84: 78-82.
47. Wucherpfennig, K. W., P. Höllsberg, J. H. Richardson, D. Benjamin, and D. A. Hafler. 1992. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc. Natl. Acad. Sci. USA 89: 2110-2114.
48. Street, S. E., Y. Hayakawa, Y. Zhan, A. M. Lew, D. MacGregor, A. M. Jamieson, A. Diefenbach, H. Yagita, D. I. Godfrey, and M. J. Smyth. 2004. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells. J. Exp. Med. 199: 879-884.
49. Girardi, M., D. E. Oppenheim, C. R. Steele, J. M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R. E. Tigelaar, and A. C. Hayday. 2001. Regulation of cutaneous malignancy by gammadelta T cells. Science 294: 605-609.
50. Liu, Z., I. E. Eltoum, B. Guo, B. H. Beck, G. A. Cloud, and R. D. Lopez. 2008. Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer. J. Immunol. 180: 6044-6053.
51. Gao, Y., W. Yang, M. Pan, E. Scully, M. Girardi, L. H. Augenlicht, J. Craft, and Z. Yin. 2003. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J. Exp. Med. 198: 433-442.
52. Lança, T., M. F. Costa, N. Gonçalves-Sousa, M. Rei, A. R. Grosso, C. Penido, and B. Silva-Santos. 2013. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic gd T lymphocytes to tumor beds. J. Immunol. 190: 6673-6680.
53. Lafont, V., F. Sanchez, E. Laprevotte, H. A. Michaud, L. Gros, J. F. Eliaou, and N. Bonnefoy. 2014. Plasticity of gd T Cells: Impact on the Anti-Tumor Response. Front. Immunol. 5: 622.
54. Coffelt, S. B., K. Kersten, C. W. Doornebal, J. Weiden, K. Vrijland, C. S. Hau, N. J. Verstegen, M. Ciampricotti, L. J. Hawinkels, J. Jonkers, and K. E. de Visser. 2015. 17-producing gd T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522: 345-348.
55. Deniger, D. C., J. S. Moyes, and L. J. Cooper. 2014. Clinical applications of gamma delta T cells with multivalent immunity. Front. Immunol. 5: 636.
56. Fisher, J. P., J. Heuijerjans, M. Yan, K. Gustafsson, and J. Anderson. 2014. gd T cells for cancer immunotherapy: A systematic review of clinical trials. OncoImmunology 3: e27572.
57. Gomes, A. Q., D. S. Martins, and B. Silva-Santos. 2010. Targeting gd T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. Cancer Res. 70: 10024-10027.
58. Kobayashi, H., Y. Tanaka, J. Yagi, N. Minato, and K. Tanabe. 2011. Phase I/II study of adoptive transfer of gd T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma. Cancer Immunol. Immunother. 60: 1075-1084.
59. Nicol, A. J., H. Tokuyama, S. R. Mattarollo, T. Hagi, K. Suzuki, K. Yokokawa, and M. Nieda. 2011. Clinical evaluation of autologous gamma delta T cellbased immunotherapy for metastatic solid tumours. Br. J. Cancer 105: 778-786.
60. Wilhelm, M., M. Smetak, K. Schaefer-Eckart, B. Kimmel, J. Birkmann, H. Einsele, and V. Kunzmann. 2014. Successful adoptive transfer and in vivo expansion of haploidentical gd T cells. J. Transl. Med. 12: 45.